OLIVIA VELAZQUEZ: Open Payments
NPI 1043769094 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 32 payments from 9 companies in 2025. Trend: 2023 $281 · 2024 $303 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Medtronic, Inc. | 4 | $69 |
| Daiichi Sankyo Inc. | 2 | $51 |
| PFIZER INC. | 2 | $48 |
| Caris MPI, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
Products named: ENHERTU, VERZENIO, KISQALI, ENDURANT IIS, KEYTRUDA, IBRANCE, MI CANCER SEEK, XT CDX.
Industry payments across FL — which companies pay providers there.
